Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 81

1.

Commentary on Kelty & Hulse (2012): is the comparison of mortality between patients prescribed implanted or oral naltrexone an unbiased and unconfounded comparison?

Hickman M, Degenhardt L, Farrell M, Hall W.

Addiction. 2012 Oct;107(10):1825-6. doi: 10.1111/j.1360-0443.2012.03966.x. No abstract available.

PMID:
22962958
2.

Examination of mortality rates in a retrospective cohort of patients treated with oral or implant naltrexone for problematic opiate use.

Kelty E, Hulse G.

Addiction. 2012 Oct;107(10):1817-24. doi: 10.1111/j.1360-0443.2012.03910.x. Epub 2012 May 17.

PMID:
22487087
3.

Excess mortality among opioid-using patients treated with oral naltrexone in Australia.

Degenhardt L, Larney S, Kimber J, Farrell M, Hall W.

Drug Alcohol Rev. 2015 Jan;34(1):90-6. doi: 10.1111/dar.12205. Epub 2014 Oct 10.

PMID:
25302627
4.

Commentary on Krupitsky et al.(2013): Refuge from the streets--parked on methadone, or seeking shelter of a depot?

Bell J.

Addiction. 2013 Sep;108(9):1638-9. doi: 10.1111/add.12248. No abstract available.

PMID:
23947734
5.

Favorable mortality profile of naltrexone implants for opiate addiction.

Reece AS.

J Addict Dis. 2010 Jan;29(1):30-50. doi: 10.1080/10550880903435988.

PMID:
20390697
6.

Retention in naltrexone implant treatment for opioid dependence.

Kunøe N, Lobmaier P, Vederhus JK, Hjerkinn B, Hegstad S, Gossop M, Kristensen O, Waal H.

Drug Alcohol Depend. 2010 Sep 1;111(1-2):166-9. doi: 10.1016/j.drugalcdep.2010.03.021. Epub 2010 May 31.

PMID:
20570059
7.

[Documented effect of methadone, but not naltrexone].

Heilig M.

Lakartidningen. 2002 Feb 7;99(6):551-2. Swedish. No abstract available.

PMID:
11881232
8.

A 'miracle cure' misunderstood.

Brewer C.

Addiction. 2012 Aug;107(8):1528. doi: 10.1111/j.1360-0443.2012.03912.x. Epub 2012 May 17. No abstract available.

PMID:
22594709
9.

Ensuring the safety of new medications and devices: are naltrexone implants safe?

Wodak AD, Ali R, Henry D, Sansom L.

Med J Aust. 2008 Apr 21;188(8):438-9. No abstract available.

PMID:
18429707
10.

[Violation of the Helsinki Declaration].

Ekgren JS.

Tidsskr Nor Laegeforen. 2014 Jan 28;134(2):136. doi: 10.4045/tidsskr.13.1668. Norwegian. No abstract available.

11.

[Registered opiate addicts in Norway].

Pedersen E.

Tidsskr Nor Laegeforen. 2014 Jan 28;134(2):136. doi: 10.4045/tidsskr.13.1667. Norwegian. No abstract available.

12.

[L.S. Stavseth and colleagues reply].

Stavseth LS, Tanum L, Kunøe N.

Tidsskr Nor Laegeforen. 2014 Jan 28;134(2):136-7. doi: 10.4045/tidsskr.13.1669. Norwegian. No abstract available.

13.

Injectable extended-release naltrexone for opioid dependence.

Throckmorton DC, Temple R, Rappaport BA, Roca R, Winchell CJ.

Lancet. 2011 Aug 20;378(9792):665-6; author reply 666. doi: 10.1016/S0140-6736(11)61332-9. No abstract available.

PMID:
21856478
14.

[The use of different forms of naltrexone in the treatment of opioid dependence].

Krupitskiĭ EM, Zvartau EE, Blokhina EA, Woody G.

Zh Nevrol Psikhiatr Im S S Korsakova. 2011;111(11 Pt 2):66-72. Russian.

PMID:
22611701
15.

Naltrexone implants -- duration, tolerability and clinical usefulness. A pilot study.

Waal H, Frogopsahl G, Olsen L, Christophersen AS, Mørland J.

Eur Addict Res. 2006;12(3):138-44.

PMID:
16778434
16.

A randomized trial of oral naltrexone for treating opioid-dependent offenders.

Coviello DM, Cornish JW, Lynch KG, Alterman AI, O'Brien CP.

Am J Addict. 2010 Sep-Oct;19(5):422-32. doi: 10.1111/j.1521-0391.2010.00070.x.

17.

Comparative treatment and mortality correlates and adverse event profile of implant naltrexone and sublingual buprenorphine.

Reece AS.

J Subst Abuse Treat. 2009 Oct;37(3):256-65. doi: 10.1016/j.jsat.2009.03.008. Epub 2009 Apr 25.

PMID:
19394789
18.

Oral naltrexone maintenance treatment for opioid dependence.

Minozzi S, Amato L, Vecchi S, Davoli M, Kirchmayer U, Verster A.

Cochrane Database Syst Rev. 2011 Apr 13;(4):CD001333. doi: 10.1002/14651858.CD001333.pub4. Review.

PMID:
21491383
19.

Naltrexone implants.

Warhaft N.

Anaesth Intensive Care. 2003 Oct;31(5):592-3. No abstract available.

PMID:
14601290
20.

[Limited role of naltrexone in the treatment of opiate addiction].

van Brussel GH.

Ned Tijdschr Geneeskd. 2001 Jul 28;145(30):1452-6. Review. Dutch.

PMID:
11503313
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk